1 “... and vomiting from a number of causes. It is an H1 receptor antagonist that demonstrates anticholinergic...”

2 “... cell astrocytoma (SEGAs) associated with tuberous sclerosis complex (TSC) that have demonstrated serial...”

3 “... cell astrocytoma (SEGAs) associated with tuberous sclerosis complex (TSC) that have demonstrated serial...”

4 “...) in patients with AF. Although NOACs have demonstrated efficacy within clinical trials in preventing stroke...”

5 “... in this review and which are based on data demonstrating bioequivalence with Orfadin (Appendix 5: Bioequivalence...”

6 “... in this review and which are based on data demonstrating bioequivalence with Orfadin (Appendix 5: Bioequivalence...”

7 “...) in patients with AF. Although NOACs have demonstrated efficacy within clinical trials in preventing stroke...”

8 “... factor alpha antagonist; or have had an inadequate response, intolerance, or demonstrated dependence...”

9 “... with guselkumab has not been demonstrated after 16 weeks...”

10 “... to demonstrate whether the addition of intravenous (IV) acetaminophen to the multimodal pain pathway for adult...”

11 “... with guselkumab has not been demonstrated after 16 weeks...”

12 “...The use of hydrogel spacers has demonstrated some clinical effectiveness in the prevention...”

13 “...The use of hydrogel spacers has demonstrated some clinical effectiveness in the prevention...”

14 “...) in patients with AF. Although NOACs have demonstrated efficacy within clinical trials in preventing stroke...”

15 “...) in patients with AF. Although NOACs have demonstrated efficacy within clinical trials in preventing stroke...”

16 “... to demonstrate whether the addition of intravenous (IV) acetaminophen to the multimodal pain pathway for adult...”

17 “.... Treatment should be discontinued if a response to risankizumab has not been demonstrated by 16 weeks...”

18 “... topical antibiotics in addition to systemic therapy, despite the literature not demonstrating a clinical...”

19 “..., it is important to determine whether sufficient clinical and cost-effectiveness has been demonstrated to warrant...”

20 “... topical antibiotics in addition to systemic therapy, despite the literature not demonstrating a clinical...”